Satoru Ito
The University Of Tokyo Entrepreneur Plaza
Tokyo, Japan
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 31, 2022
Transient Depletion of CD4+ Cells Induces Remodeling of the TCR Repertoire in Gastrointestinal Cancer.
Journal: Cancer immunology research
Published: December 03, 2020
Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma.
Journal: Cancers
Published: April 09, 2019
First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: December 02, 2018
TCR Repertoire Analysis Reveals Mobilization of Novel CD8+ T Cell Clones Into the Cancer-Immunity Cycle Following Anti-CD4 Antibody Administration.
Journal: Frontiers in immunology
Published: July 19, 2018
Prostaglandin E-major urinary metabolite as a noninvasive surrogate marker for infantile necrotizing enterocolitis.
Journal: Journal of pediatric surgery
Published: May 19, 2018
Prostaglandin E-major Urinary Metabolite as a Biomarker for Pediatric Ulcerative Colitis Activity.
Journal: Journal of pediatric gastroenterology and nutrition
Published: December 02, 2016
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia.
Journal: Respiratory medicine
Published: September 28, 2016
Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice.
Journal: Cancer immunology research
Published: October 08, 2014
Last Updated: 09/26/2026